Literature DB >> 14075156

VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS.

J H BARON, A M CONNELL, J E LENNARD-JONES.   

Abstract

Entities:  

Keywords:  COLITIS; MUCOUS MEMBRANE; PATHOLOGY; PROCTITIS; SIGMOIDOSCOPY; STATISTICS

Mesh：

Year:  1964        PMID： 14075156      PMCID： PMC1812908          DOI： 10.1136/bmj.1.5375.89

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  2 in total

1.  Sulphasalazine and salicylazosulphadimidine in ulcerative colitis.

Authors:  J H BARON; A M CONNELL; J E LENNARD-JONES; F A JONES
Journal:  Lancet       Date:  1962-05-26       Impact factor: 79.321

2.  Statistical methods applied to the clinical diagnosis of thyrotoxicosis.

Authors:  J CROOKS; I P MURRAY; E J WAYNE
Journal:  Q J Med       Date:  1959-04
  2 in total
  162 in total

1.  Controlled trial of disodium cromoglycate in chronic persistent ulcerative colitis.

Authors:  N A Buckell; S R Gould; D W Day; J E Lennard-Jones; A M Edwards
Journal:  Gut       Date:  1978-12       Impact factor: 23.059

Review 2.  Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis.

Authors:  Eduardo Garcia Vilela; Henrique Osvaldo da Gama Torres; Fabiana Paiva Martins; Maria de Lourdes de Abreu Ferrari; Marcella Menezes Andrade; Aloísio Sales da Cunha
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

3.  Incidence and prevalence of ulcerative colitis in Punjab, North India.

Authors:  A Sood; V Midha; N Sood; A S Bhatia; G Avasthi
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

Review 4.  Assessing disease activity and disease activity indices for inflammatory bowel disease.

Authors:  Feng Xiao Li; Lloyd R Sutherland
Journal:  Curr Gastroenterol Rep       Date:  2002-12

Review 5.  Evaluation of new therapies for inflammatory bowel disease.

Authors:  E Carty; D S Rampton
Journal:  Br J Clin Pharmacol       Date:  2003-10       Impact factor: 4.335

6.  Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial.

Authors:  A B Hawthorne; T K Daneshmend; C J Hawkey; A Belluzzi; S J Everitt; G K Holmes; C Malkinson; M Z Shaheen; J E Willars
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

7.  CONTROLLED TRIAL OF SULPHASALAZINE IN THE TREATMENT OF ULCERATIVE COLITIS.

Authors:  A P DICK; M J GRAYSON; R G CARPENTER; A PETRIE
Journal:  Gut       Date:  1964-10       Impact factor: 23.059

8.  COMPARISON OF ORAL AND RECTAL STEROIDS IN THE TREATMENT OF PROCTOCOLITIS.

Authors:  J J MISIEWICZ; J E LENNARD-JONES; F A JONES
Journal:  Proc R Soc Med       Date:  1964-07

9.  B1a lymphocytes in the rectal mucosa of ulcerative colitis patients.

Authors:  Lino Polese; Riccardo Boetto; Giuseppe De Franchis; Imerio Angriman; Andrea Porzionato; Lorenzo Norberto; Giacomo Carlo Sturniolo; Veronica Macchi; Raffaele De Caro; Stefano Merigliano
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

10.  Proposal of a new clinical index predictive of endoscopic severity in ulcerative colitis.

Authors:  Francesco Azzolini; Cristiano Pagnini; Lorenzo Camellini; Antonella Scarcelli; Alberto Merighi; Anna Maria Primerano; Angela Bertani; Aldo Antonioli; Federico Manenti; Gian Piero Rigo
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.